Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / #OTHER
-
Shares outstanding
-
67,017,829
-
Total 13F shares
-
57,722,564
-
Share change
-
-1,193,983
-
Total reported value
-
$306,424,712
-
Price per share
-
$5.31
-
Number of holders
-
106
-
Value change
-
-$6,672,501
-
Number of buys
-
66
-
Number of sells
-
34
Institutional Holders of Generation Bio Co. - #OTHER (GBIO) as of Q3 2022
As of 30 Sep 2022,
Generation Bio Co. - #OTHER (GBIO) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,722,564 shares.
The largest 10 holders included
FMR LLC, Atlas Venture Life Science Advisors, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Bellevue Group AG, BlackRock Inc., T. Rowe Price Investment Management, Inc., PFM Health Sciences, LP, Artal Group S.A., FARALLON CAPITAL MANAGEMENT LLC, and VANGUARD GROUP INC.
This page lists
106
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.